Putzki N - Search Results

1

Mitoxantrone does not restore the impaired suppressive function of natural regulatory T cells in patients suffering from multiple sclerosis. A longitudinal ex vivo and in vitro study.

Putzki N, Kumar M, Kreuzfelder E, Grosse-Wilde H, Diener HC, Limmroth V. Putzki N, et al. Eur Neurol. 2009;61(1):27-32. doi: 10.1159/000165346. Epub 2008 Oct 24. Eur Neurol. 2009. PMID: 18948697 Clinical Trial.

2

Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis.

Putzki N, Pfriem A, Limmroth V, Yaldizli O, Tettenborn B, Diener HC, Katsarava Z. Putzki N, et al. Eur J Neurol. 2009 Feb;16(2):262-7. doi: 10.1111/j.1468-1331.2008.02406.x. Epub 2008 Dec 9. Eur J Neurol. 2009. PMID: 19138330

3

Natalizumab is effective as second line therapy in the treatment of relapsing remitting multiple sclerosis.

Putzki N, Kollia K, Woods S, Igwe E, Diener HC, Limmroth V. Putzki N, et al. Eur J Neurol. 2009 Mar;16(3):424-6. doi: 10.1111/j.1468-1331.2008.02519.x. Eur J Neurol. 2009. PMID: 19187261

4

Efficacy of natalizumab in second line therapy of relapsing-remitting multiple sclerosis: results from a multi-center study in German speaking countries.

Putzki N, Yaldizli O, Mäurer M, Cursiefen S, Kuckert S, Klawe C, Maschke M, Tettenborn B, Limmroth V. Putzki N, et al. Eur J Neurol. 2010 Jan;17(1):31-7. doi: 10.1111/j.1468-1331.2009.02728.x. Epub 2009 Jul 9. Eur J Neurol. 2010. PMID: 19614963 Clinical Trial.

5

Peripheral nervous system involvement in multiple sclerosis.

Gartzen K, Katzarava Z, Diener HC, Putzki N. Gartzen K, et al. Among authors: putzki n. Eur J Neurol. 2011 May;18(5):789-91. doi: 10.1111/j.1468-1331.2010.03149.x. Eur J Neurol. 2011. PMID: 20629712

6

Secondary myelodysplastic syndrome following long-term treatment with azathioprine in patients with multiple sclerosis.

Putzki N, Knipp S, Ramczykowski T, Vago S, Germing U, Diener HC, Limmroth V. Putzki N, et al. Mult Scler. 2006 Jun;12(3):363-6. doi: 10.1191/135248506ms1307cr. Mult Scler. 2006. PMID: 16764353

7

Prevalence and severity of multiple-sclerosis-associated fatigue in treated and untreated patients.

Putzki N, Katsarava Z, Vago S, Diener HC, Limmroth V. Putzki N, et al. Eur Neurol. 2008;59(3-4):136-42. doi: 10.1159/000111876. Epub 2007 Nov 30. Eur Neurol. 2008. PMID: 18057900

8

Fatigue is not associated with impaired function of regulatory T cells in untreated patients with multiple sclerosis.

Yaldizli O, Kumar M, Vago S, Kreuzfelder E, Limmroth V, Putzki N. Yaldizli O, et al. Among authors: putzki n. Eur Neurol. 2009;62(6):321-6. doi: 10.1159/000236375. Epub 2009 Sep 10. Eur Neurol. 2009. PMID: 19752558

9

Effects of natalizumab on circulating B cells, T regulatory cells and natural killer cells.

Putzki N, Baranwal MK, Tettenborn B, Limmroth V, Kreuzfelder E. Putzki N, et al. Eur Neurol. 2010;63(5):311-7. doi: 10.1159/000302687. Epub 2010 May 5. Eur Neurol. 2010. PMID: 20453514

10

Increased basal-ganglia activation performing a non-dystonia-related task in focal dystonia.

Obermann M, Yaldizli O, de Greiff A, Konczak J, Lachenmayer ML, Tumczak F, Buhl AR, Putzki N, Vollmer-Haase J, Gizewski ER, Diener HC, Maschke M. Obermann M, et al. Among authors: putzki n. Eur J Neurol. 2008 Aug;15(8):831-8. doi: 10.1111/j.1468-1331.2008.02196.x. Eur J Neurol. 2008. PMID: 18557921

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters